BP-C1 in Short-term Treatment of Metastatic Pancreatic Cancer
Status:
Completed
Trial end date:
2016-03-04
Target enrollment:
Participant gender:
Summary
The aim of this study is to investigate the short-term effect and tolerability BP-C1 in
patients with metastatic pancreatic cancer who has undergone guideline-recommended
chemotherapy.
Phase:
Phase 2
Details
Lead Sponsor:
Meabco A/S
Collaborators:
Meddoc Meddoc AS Norwegian University of Life Sciences